| Novel pyrrolo-1, 5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo SA Bright, AM McElligott, JW O'connell, L O'connor, P Carroll, G Campiani, ... British journal of cancer 102 (10), 1474-1482, 2010 | 24 | 2010 |
| I-CARE, a European prospective cohort study assessing safety and effectiveness of biologics in inflammatory bowel disease L Peyrin-Biroulet, JF Rahier, J Kirchgesner, V Abitbol, S Shaji, A Armuzzi, ... Clinical Gastroenterology and Hepatology 21 (3), 771-788. e10, 2023 | 18 | 2023 |
| Selective resection of type 1 gastric neuroendocrine neoplasms and the risk of progression in an endoscopic surveillance programme JL Chin, J O’Connell, C Muldoon, N Swan, JV Reynolds, N Ravi, ... Digestive surgery 38 (1), 38-45, 2021 | 14 | 2021 |
| Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis J O’Connell, C Rowan, R Stack, G Harkin, V Parihar, G Chan, N Breslin, ... European Journal of Gastroenterology & Hepatology 30 (9), 1019-1026, 2018 | 11 | 2018 |
| C-reactive protein and c-reactive protein-based scores to predict survival in esophageal and junctional adenocarcinoma: systematic review and meta-analysis CM Lorton, L Higgins, N O’Donoghue, C Donohoe, J O’Connell, ... Annals of Surgical Oncology, 1-13, 2022 | 8 | 2022 |
| P095 Association between tissue oncostatin M expression and infliximab response in corticosteroid refractory acute severe ulcerative colitis J O'Connell, P McDonagh, N Clarke, A Buckley, C Dunne, K Hartery, ... Journal of Crohn's and Colitis 13 (Supplement_1), S133-S134, 2019 | 4 | 2019 |
| Characteristics and outcomes of acute colitis diagnosed on cross-sectional imaging presenting via the emergency department in an Irish academic medical centre J O’Connell, S Keohane, A McGreal-Bellone, P McDonagh, ... Irish Journal of Medical Science (1971-) 189, 1115-1121, 2020 | 3 | 2020 |
| Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis J O’connell, J Doherty, A Buckley, D Cormican, C Dunne, K Hartery, ... Intestinal research 20 (3), 381, 2022 | 2 | 2022 |
| Tu1827–Maintenance Levels of Vedolizumab Do Not Correlate with Clinical Remission in IBD Patients JM Tessolini, G Bajaj, P Zezos, JW O'Connell, V Huang, K Croitoru, ... Gastroenterology 156 (6), S-1140, 2019 | 1 | 2019 |
| Helicobacter pylori: High dose amoxicillin does not improve primary or secondary eradication rates in an Irish cohort C Costigan, AM O'Sullivan, J O'Connell, S Sengupta, T Butler, S Molloy, ... World Journal of Clinical Cases 12 (16), 2773-2779, 2024 | | 2024 |
| Cloud technology and capsule endoscopy: A single-center users’ experience of remote online video analysis and reporting C Costigan, C Walker, J O'Connell, E Omallao, T Manoharan, N Eagle, ... Endoscopy International Open 12 (02), E227-E230, 2024 | | 2024 |
| ASO Visual Abstract: C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-analysis CM Lorton, L Higgins, C Donohoe, D Mockler, JV Reynolds, D Walsh, ... Annals of Surgical Oncology 29 (3), 1866-1867, 2022 | | 2022 |
| P102 Changes in serum immune protein profiles following vedolizumab therapy in Inflammatory Bowel Disease J O’Connell, F O’Connell, J O’Sullivan, D Kevans Journal of Crohn's and Colitis 16 (Supplement_1), i198-i199, 2022 | | 2022 |
| Association between tissue oncostatin M expression and infliximab response in corticosteroid refractory acute severe ulcerative colitis J O'Connell, P McDonagh, N Clarke, A Buckley, C Dunne, K Hartery, ... JOURNAL OF CROHNS & COLITIS 13, S134-S134, 2019 | | 2019 |
| P401 Association between induction vedolizumab drug levels and therapy outcome in inflammatory bowel disease J O'Connell, MS Ismail, M McCormack, P McDonagh, R Argue, N Breslin, ... Journal of Crohn's and Colitis 13 (Supplement_1), S308-S309, 2019 | | 2019 |
| P704 Association between trough levels of vedolizumab and therapy outcome in a cohort of patients with inflammatory bowel disease J O'Connell, P McDonagh, K Hazel, J Fiona, C Dunne, R Farrell, ... Journal of Crohn's and Colitis 13 (Supplement_1), S473-S473, 2019 | | 2019 |
| Comparison of the Durability of Subcutaneous Anti-TNF Therapy Response between Ulcerative Colitis and Crohn’s Disease C McShane, GS Mellotte, JW O'Connell, S Mc Kiernan, F MacCarthy, ... Gastroenterology 152 (5), S587-S588, 2017 | | 2017 |
| 31 The prognostic value of transient elastography: a single centre irish study S Naimimohasses, O El-Sherif, J O'Connell, B Hynes, H Irish, C Quinn, ... Gut 66, A12, 2017 | | 2017 |
| P491 Comparison of the durability of response to subcutaneous anti-TNF therapy between ulcerative colitis and Crohn's disease G Mellotte, C McShane, J O'Connell, S Mc Kiernan, F Mac Carthy, ... Journal of Crohn's and Colitis 11 (suppl_1), S328-S328, 2017 | | 2017 |
| P141 Characteristics and outcomes of acute colitis presenting via the emergency department in an Irish academic medical centre J O'Connell, S Keohane, A McGreal-Bellone, S Naimimohasse, ... Journal of Crohn's and Colitis 11 (suppl_1), S147-S148, 2017 | | 2017 |
